|
 |
ColesevelamThis page contains recent news articles, when available, and an overview of Colesevelam but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Medications in this class--cholestyramine, colestipol, and colesevelam--come in pill or powder form. The powder must be mixed with water or juice before KFSM CHOLESTEROL : UN NOUVEAU TRAITEMENT pour le faire baisser encore plus - Jul 3, 2009 Cet essai indique l'efficacité adjuvante du chlorhydrate de colesevelam pour obtenir une réduction significative du cholestérol LDL, fraction la plus santé log - communauté des professionnels de santé MRI study shows plaque lipid core depletion with intensive lipid ... - Apr 7, 2009 ...extended-release niacin, and colesevelam, a bile-acid-binding agent. After one year, LDL-cholesterol and apoB levels were reduced approximately 50%. TheHeart.Org Intensive Lipid Lowering Causes Atherosclerotic Plaque Lipids to ... - Mar 31, 2009 ...or (3) atorvastatin plus extended-release niacin, plus colesevelam 3.8 g/day. The patients in regimens 1 and 2 also took appropriate placebos. DG News Colesevelam nel diabete - Mar 15, 2009 Il colesevelam, un legante gli acidi biliari, potrebbe in futuro rappresentare una nuova opzione terapeutica nel diabete tipo 2, ma necessitano ulteriori Pillole.org Diabete mellito di tipo 2 non controllato da Metformina ... - Mar 16, 2009 Un totale di 316 pazienti sono stati assegnati in maniera casuale a ricevere trattamento con 3.75 g/giorno di Colesevelam ( n=159) o con placebo ( n=157 ). XagenaSalute Cholestagel werkzaam bij Familiaire Hypercholesterolemie - Mar 2, 2009 Het resultaat laat zien dat Genzyme's cholesterolverlagende therapie Cholestagel (colesevelam) een significante verlaging geeft van het low density Nieuwsbank (persbericht) (abonnement) High cholesterol - Jan 21, 2009 Colesevelam (Cholestagel) is another cholesterol drug. It's usually used together with a statin. Ezetimibe (Ezetrol) is a newer drug that stops your body guardian.co.uk, FDA Approved Drugs During 2008 - Dec 22, 2008 Welchol (colesevelam hydrochloride); For the improvement of glycemic control in adults with type 2 diabetes mellitus; Daiichi Sankyo; Approved January 2008 eMaxHealth.com, Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With ... - Nov 11, 2008 According to the findings, colesevelam HCl was well-tolerated and produced a significant reduction in low density lipoprotein (LDL) or "bad" cholesterol MarketWatch Colesevelam Safe, Effective in Lowering Cholesterol in Children ... - Nov 12, 2008 ..."The use of colesevelam may improve the management of low-density lipoprotein [LDL] -cholesterol abnormalities in paediatric patients with heterozygous DG News Colesevelam hydrochloride lowered HbA1c in patients with type 2 ... - Oct 17, 2008 Treatment with colesevelam hydrochloride demonstrated improvements in glycemic and lipid parameters in patients with type 2 diabetes who were inadequately Endocrine Today, Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes ... - Oct 13, 2008 In total, 316 subjects were randomized (159 to colesevelam hydrochloride, 3.75 g/d, and 157 to matching placebo). The primary efficacy parameter was mean Archives of Internal Medicine Colesevelam Safe, Effective in Patients With Diabetes Receiving ... - Jul 29, 2008 Specify results of a pilot trial of colesevelam for patients with diabetes. Identify outcomes improved with colesevelam vs placebo in patients with poorly Medscape (subscription) Efficacy and Safety of Colesevelam in Patients With Type 2 ... - Jul 28, 2008 Study Question: What are the glucose-lowering effects of colesevelam treatment in subjects with type 2 diabetes mellitus (T2DM) that is not adequately Cardiosource, Efficacy and Safety of Colesevelam in Patients With Type 2 ... - Jul 28, 2008 In total 287 subjects (52% men; mean age, 57 years; with a mean baseline glycated hemoglobin level of 8.3%) were randomized: 147 to receive colesevelam Archives of Internal Medicine Adding Colesevelam to Treatment Improves Glucose Profile in ... - May 21, 2008 By Ric Susman ORLANDO, Fla -- May 20, 2008 -- Adding the cholesterol-lowering agent colesevelam hydrochloride to a diabetes regimen that already includes DG News COLESEVELAM HYDROCHLORIDE - May 20, 2008 WelChol is indicated for LDL-C lowering. WelChol is the top-selling branded drug in the bile acid sequestrants (BAS) class. WelChol is different from most Lifescience-online, Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added ... - May 30, 2008 Drugs that have not been tested for interaction with colesevelam, especially those with a narrow therapeutic index, should also be administered at least 4 Earthtimes (press release), FDA Safety Changes: Janumet, WelChol, Rituxan - May 7, 2008 Describe the risk for elevated triglyceride levels in patients receiving colesevelam HCl therapy for type 2 diabetes. Explain the appropriate management of Medscape (subscription) Data From Pooled Analyses Demonstrates Welchol, Combined With ... - May 16, 2008 Drugs that have not been tested for interaction with colesevelam, especially those with a narrow therapeutic index, should also be administered at least 4 Earthtimes (press release), Approval for Adjunctive Drug to Treat Type 2 Diabetes - Apr 10, 2008 The FDA has approved Welchol (colesevelam hydrochloride) to reduce blood glucose in adults with type 2 diabetes mellitus in combination with metformin, Renal and Urology News, Welchol(TM) Added to the American College of Endocrinology ... - Apr 15, 2008 PARSIPPANY, NJ, April 15 -- Daiichi Sankyo announced today that Welchol(TM) (colesevelam HCl) has been added to the American College of Endocrinology (ACE) Earthtimes, Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year - Feb 14, 2008 Synvisc-ONE(TM) (hylan GF 20) and Cholestagel® (colesevelam hydrochloride) in the European Union, and Elaprase® (idursulfase) in Japan - and secured Lifescience-online, Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year - Feb 13, 2008 Synvisc-ONE(TM) (hylan GF 20) and Cholestagel(R) (colesevelam hydrochloride) in the European Union, and Elaprase(R) (idursulfase) in Japan-and secured PR Newswire (press release), Welchol(TM) (colesevelam HCl) Receives FDA Approval To Reduce ... - Jan 19, 2008 Daiichi Sankyo, Inc., announced that the United States Food and Drug Administration (FDA) has approved Welchol(TM) (colesevelam HCl) to improve glycemic Medical News Today (press release), MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA ... - Jan 18, 2008 Daiichi Sankyo, Inc. announced today that the United States Food and Drug Administration (FDA) has approved WelChol(R) (colesevelam HCl) Tablets as the PR Newswire (press release), WelChol Gains Type 2 Diabetes Indication - Jan 25, 2008 Labeling states that WelChol (colesevelam HCl) has not been tested as a single agent or in combination with a dipeptidyl peptidase-4 inhibitor, FDA news (subscription), Genzyme ship out first batches of cholesterol drug - Oct 25, 2007 ONE of the world’s leading biotechnology companies, Genzyme, this week shipped the first batches of Cholestagel (colesevelam hydrochloride) from their Waterford News, Genzyme (GENZ) Reports Strong Earnings Growth in Third Quarter - Oct 24, 2007 Union clearance to market cholestagelâ® (colesevelam hydrochloride), a cholesterol-lowering agent for the treatment of primary hypercholesterolemia. StreetInsider.com (subscription), Genzyme Corp announces launch of Cholestagel in Europe - Oct 24, 2007 ...declared on 23 October that it has introduced Cholestagel (colesevelam hydrochloride), its first commercially available cardiovascular product, Trading Markets (press release), Genzyme Launches Cholestagel(R) in Europe - Oct 23, 2007 Colesevelam has been approved for use in the United States since 2000, where it is marketed by Daiichi Sankyo Inc. under the trade name welchol(R). CNNMoney.com Pharmaceutical manufacturing: news in brief - Oct 26, 2007 Genzyme has launched its cardiovascular product Cholestagel (colesevelam hydrochloride) in Europe. Cholestagel is a polymer in tablet form that lowers LDL DrugResearcher.com, Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize - Oct 1, 2007 About WelChol(R) WelChol (colesevelam HCI) is indicated for LDL-C lowering and was approved by the US Food and Drug Administration (FDA) for marketing in Earthtimes.org Cholesterol Drug Hits Diabetes With One-Two Punch - Jul 12, 2007 NewsMax.com,Results from the clinical trial demonstrated that the compound colesevelam HCl, in combination with Sulfonylurea-based therapy in patients with inadequately New Drug May Soon Help Type 2 Diabetics - Jul 9, 2007 Post ChronicleResearchers led by Professor Vivian Fonseca at Tulane University conducted a clinical trial that demonstrated the compound colesevelam HCl, in combination Single Drug to Check Both Glucose and Cholesterol in Diabetics on ... - Jul 8, 2007 MedIndia,Lead researcher Dr. Vivian A. Fonseca, Professor of Medicine and Pharmacology at Tulane University School of Medicine, says that the compound colesevelam Colesevelam HCl Lowers A1C, LDL Cholesterol In Patients With ... - Jun 25, 2007 eMaxHealth.com,Colesevelam HCl can lower both A1C and LDL cholesterol levels in patients with type 2 diabetes mellitus who were uncontrolled on a metformin-based regimen. New Study Demonstrates Colesevelam HCl Lowers Both A1C and LDL ... - Jun 23, 2007 PR Newswire (press release),The new colesevelam HCl clinical data findings from the pivotal studies are consistent with the pilot study findings. The data was included in Daiichi New Study Demonstrates Colesevelam HCl Lowers Both A1C And LDL ... - Jun 23, 2007 Genetic Engineering News (press release),Data to be presented at the American Diabetes Association's (ADA) 67th Annual Scientific Sessions in Chicago demonstrate that colesevelam HCl can lower both New Drug Combination Further Reduces Cholesterol - Jun 8, 2007 Therapeutics Daily (subscription) (press release),The recent study revealed that WelChol (colesevelam HCl) combined with ezetim ibe (a cholesterol absorption inhibitor) reduced LDL by a mean 32 percent, KineMed Evaluates The Mechanism Of Action For Colesevelam In ... - May 22, 2007 Medical News Today (press release),KineMed will apply its proprietary translational medicine technology, KineMarker(TM), to measure the effects of colesevelam HCl on multiple metabolic Cholesterol-Lowering Drug Combined With Metformin Improves Glucose ... - Apr 16, 2007 DG NewsIn an earlier, smaller study of 65 patients with type 2 diabetes, HbA1c levels were reduced by 0.5% when colesevelam was added to an existing oral Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to ... - Mar 29, 2007 Drug Newswire (press release),A study recently published in the November issue of Current Medical Research and Opinion showed that taking WelChol(R) (colesevelam HCI) in combination with Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to ... - Mar 28, 2007 PR-Inside.com (Pressemitteilung),The, "Lipid Lowering Effects of Colesevelam HCI in Combination with Ezetimibe" (1) study was also presented in November at the American Heart Association's Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug ... - Jan 3, 2007 PipelineReview.com (press release),Announced today that it has filed a supplemental New Drug Application (sNDA) with the US Food and Drug Administration (FDA) for WelChol® (colesevelam HCl) Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug ... - Jan 3, 2007 Medical News Today (press release),...with the US Food and Drug Administration (FDA) for WelChol(R) (colesevelam HCl) to improve glycemic control in patients with type 2 diabetes mellitus. Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude ... - Jan 10, 2007 Oxfordshire Bioscience Network (press release),Other revenue-including oncology revenue, sales of pharmaceutical intermediates, R&D revenue, and royalties from the sale of WelChol® (colesevelam FDA Asked to Approve Use of Cholesterol Drug WelChol as a Diabetes ... - Jan 4, 2007 Diabetes Drug Report,Daiichi Sankyo, Inc. announced it has asked the US Food and Drug Administration (FDA) to approve use of its cholesterol drug WelChol® (colesevelam HCl) as a Daiichi Sankyo, Inc. Announces Filing of New Drug Application for ... - Nov 29, 2006 PipelineReview.com (press release),...the fastest growing angiotensin receptor blocker on the market, and WelChol(R) (colesevelam HCl), the number one branded bile acid sequestrant. Genzyme Reports Strong Third-Quarter Financial Results Oct 12, 2006 Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride) -- was ... -Yahoo! News (press release) Genzyme Reports Strong Third-Quarter Financial Results Oct 12, 2006 Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- was ... -Drug Newswire (press release), Rosuvastatin plus diet in hypercholesterolemic adults unable to ... Aug 27, 2006 Eighteen patients subsequently failed to reach LDL-cholesterol goals with non-statin lipid-lowering therapies alone ( Colesevelam, 10 patients; Ezetimibe, 8 ... -Xagena.it Rosuvastatin plus diet in hypercholesterolemic adults unable to ... Aug 27, 2006 Eighteen patients subsequently failed to reach LDL-cholesterol goals with non-statin lipid-lowering therapies alone ( Colesevelam, 10 patients; Ezetimibe, 8 ... -Xagena.it Study of Tolevamer for C. difficile-Associated Diarrhea Published ... Aug 16, 2006 R) (sevelamer hydrochloride) controls serum phosphorus in patients with chronic kidney disease on dialysis, and WelChol(R) (colesevelam hydrochloride) reduces ... -DG News Results of Phase 2 Study of Tolevamer for C. difficile-Associated ... Aug 16, 2006 ...sevelamer hydrochloride) controls serum phosphorus in patients with chronic kidney disease on dialysis, and WelChol® (colesevelam hydrochloride) reduces LDL ... -Oxfordshire Bioscience Network Feeling squeezed by statins Aug 8, 2006 ...grapefruit. Ezetimibe (Zetia), colesevelam (WelChol) and niacin are other cholesterol-lowering options that work safely with grapefruit. ... -NorthJersey.com 1st Clinical Trial To Show Colesevelam HCl Plus Stable Oral ... Jun 26, 2006 The first data to demonstrate the effect of WelChol® (colesevelam hydrochloride) on glucose lowering was presented today at The American Diabetes ... -Medical News Today Delivers Solid Earnings Growth Based on Strong Top-Line ... Jul 18, 2006 Other revenue-including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride)-increased 30 ... -Oxfordshire Bioscience Network Genzyme Reports Second-Quarter Financial Results Jul 12, 2006 ...revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- increased ... -Drug Newswire Addition Of A Bile Acid Sequestrant (WelChol, Colesevelam HCl) To ... Apr 19, 2006 Data published today in the April 15 issue of the American Journal of Cardiology demonstrated that adding WelChol(R) (colesevelam hydrochloride) to stable ... - Medical News Today Genzyme Reports Financial Results for the First Quarter of 2006 Apr 19, 2006 Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- was ... - MSN Money US Subsidiaries Join Together to Form Daiichi Sankyo, Inc. Apr 3, 2006 ...six products, including BENICAR(R) (olmesartan medoxomil), BENICAR(R) HCT (olmesartan medoxomil-hydrochlorothiazide), WelChol(R) (colesevelam HCl), FLOXIN(R ... - PR Newswire US Subsidiaries Join Together to Form Daiichi Sankyo, Inc. Apr 3, 2006 ...supports six products, including BENICAR® (olmesartan medoxomil), BENICAR® HCT (olmesartan medoxomil-hydrochlorothiazide), WelChol® (colesevelam HCl), FLOXIN ... - Market Wire Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue Jan 9, 2006 ...including oncology revenue, sales of pharmaceutical intermediates, R&D revenue, and royalties from the sale of WelChol(R) (colesevelam hydrochloride) -- was ... - MSN Money : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |